These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 24222106

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.
    Kim Y, Schmidt M, Endo T, Lu D, Carson D, Schmidt-Wolf IG.
    In Vivo; 2011; 25(6):887-93. PubMed ID: 22021681
    [Abstract] [Full Text] [Related]

  • 3. Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.
    Von Schulz-Hausmann SA, Schmeel LC, Schmeel FC, Schmidt-Wolf IG.
    Anticancer Res; 2014 Aug; 34(8):4101-8. PubMed ID: 25075035
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of Wnt inhibitors in pancreatic cancer.
    Wall I, Schmidt-Wolf IG.
    Anticancer Res; 2014 Oct; 34(10):5375-80. PubMed ID: 25275031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeting renal cancer with a combination of WNT inhibitors and a bi-functional peptide.
    Koller CM, Kim Y, Schmidt-Wolf IG.
    Anticancer Res; 2013 Jun; 33(6):2435-40. PubMed ID: 23749892
    [Abstract] [Full Text] [Related]

  • 9. ME-143 Is Superior to Genistein in Suppression of WNT Signaling in Colon Cancer Cells.
    Pintova S, Planutis K, Planutiene M, Holcombe RF.
    Anticancer Res; 2017 Apr; 37(4):1647-1653. PubMed ID: 28373425
    [Abstract] [Full Text] [Related]

  • 10. In Vitro Apoptosis Induction by Fenofibrate in Lymphoma and Multiple Myeloma.
    Schmeel LC, Schmeel FC, Schmidt-Wolf IGH.
    Anticancer Res; 2017 Jul; 37(7):3513-3520. PubMed ID: 28668840
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-proliferative activity of CGK012 against multiple myeloma cells via Wnt/β-catenin signaling attenuation.
    Choi PJ, O Y, Her JH, Yun E, Song GY, Oh S.
    Leuk Res; 2017 Sep; 60():103-108. PubMed ID: 28772205
    [Abstract] [Full Text] [Related]

  • 14. In vivo efficacy of the diuretic agent ethacrynic acid against multiple myeloma.
    Kim Y, Gast SM, Endo T, Lu D, Carson D, Schmidt-Wolf IG.
    Leuk Res; 2012 May; 36(5):598-600. PubMed ID: 22386728
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased in vivo efficacy of lenalidomide and thalidomide by addition of ethacrynic acid.
    Schmidt M, Kim Y, Gast SM, Endo T, Lu D, Carson D, Schmidt-Wolf IG.
    In Vivo; 2011 May; 25(3):325-33. PubMed ID: 21576405
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.
    Zhang KS, Zhou Q, Wang YF, Liang LJ.
    Oncol Rep; 2013 Sep; 30(3):1430-8. PubMed ID: 23799613
    [Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide and 2-methoxyestradiol reduce beta-catenin accumulation after proteasome inhibition and enhance the sensitivity of myeloma cells to Bortezomib.
    Zhou L, Hou J, Fu W, Wang D, Yuan Z, Jiang H.
    Leuk Res; 2008 Nov; 32(11):1674-83. PubMed ID: 18485479
    [Abstract] [Full Text] [Related]

  • 19. Smenospongidine suppresses the proliferation of multiple myeloma cells by promoting CCAAT/enhancer-binding protein homologous protein-mediated β-catenin degradation.
    Park S, Hwang IH, Kim J, Chung YH, Song GY, Na M, Oh S.
    Arch Pharm Res; 2017 May; 40(5):592-600. PubMed ID: 28275987
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.